Review
Published on 19 Dec 2022
Pregnancy and antibody-mediated CNS disorders: What do we know and what should we know?
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1048502
- 5,183 views
- 3 citations
Type at least 3 characters
1,081 articles
Articles
Original Research
Published on 14 Dec 2022
Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1016377
- 14,079 views
- 12 citations
Case Report
Published on 14 Dec 2022
Case report: Pain in anti-DPPX encephalitis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1091688
- 2,455 views
- 4 citations
Original Research
Published on 09 Dec 2022
Determinants of early working impairments in multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1062847
- 3,030 views
- 8 citations
Case Report
Published on 08 Dec 2022
Misdiagnosis of Susac syndrome as demyelinating disease and primary angiitis of the central nervous system: A case report
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1055038
- 2,545 views
Case Report
Published on 02 Dec 2022
Case report: MOG-IgG-associated encephalitis with Epstein-Barr virus infection and Alzheimer's pathologic change in cerebrospinal fluid
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1013413
- 3,699 views
- 2 citations
Case Report
Published on 01 Dec 2022
Neuromyelitis optica spectrum disorders associated with AQP4-positive-cancer—A case series
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1071519
- 2,618 views
- 4 citations
Original Research
Published on 01 Dec 2022
CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1018785
- 7,509 views
- 17 citations
Systematic Review
Published on 30 Nov 2022
Driving ability and predictors for driving performance in Multiple Sclerosis: A systematic review
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1056411
- 2,456 views
- 3 citations
Editorial
Published on 29 Nov 2022
Editorial: Immune-mediated disorders of the spinal cord: Diagnosis, treatment strategies, and outcomes in the 21st century
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1087631
- 1,541 views
Case Report
Published on 29 Nov 2022
Case report: Varicella-zoster virus infection triggering progressive encephalomyelitis with rigidity and myoclonus
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1042988
- 3,099 views
- 2 citations
Editorial
Published on 22 Nov 2022
Editorial: Pain in multiple sclerosis and experimental autoimmune encephalomyelitis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1093254
- 1,376 views
Original Research
Published on 17 Nov 2022
Ovarian resection in anti-N-methyl-D-aspartate receptor encephalitis: A comparison of surgical approaches
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1043785
- 2,005 views
- 1 citation
Original Research
Published on 15 Nov 2022
Elevated plasma D-dimer levels in patients with anti-N-methyl-D-aspartate receptor encephalitis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1022785
- 1,575 views
- 2 citations
Original Research
Published on 14 Nov 2022
Rebaseline no evidence of disease activity (NEDA-3) as a predictor of long-term disease course in a Norwegian multiple sclerosis population
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1034056
- 3,969 views
- 6 citations
Review
Published on 10 Nov 2022
The role of type I IFN in autoimmune and autoinflammatory diseases with CNS involvement
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1026449
- 5,258 views
- 10 citations